ArticleBMJ oncology2024
Health-related quality of life outcomes reporting associated with FDA approvals in haematology and oncology.
Medhavi Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it